US Patent 7247444 Use of interleukin-19 to treat cervical cancer

Patent 7247444 was granted and assigned to ZymoGenetics on July, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 16 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 16 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Patricia A. McKernan1

Yasmin A. Chandrasekher1

Edits on 1 Sep, 2023

"Add patent abstract"

Golden AI

edited on 1 Sep, 2023

Edits made to:

Article (+500 characters)

Article

Patent abstract

The present invention relates to the anti-cancer activity of IL-19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of cervical cancer cells, treating cervical cancer, amongst other uses disclosed. IL-19 polypeptides can be administered alone, or can be fused to cytotoxic moieties, and can be administered in conjunction with radiation or chemotherapeutic agents.

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=07247444

Edits on 22 May, 2023

"Remove leading 0 from patent number"

Golden AI